Table 1 Characteristics of study participants
ID | Sex | Age | ART duration (months) | CD4 counts | Viral load (HIV copies/mL) | Medical complexity | Sample collection |
|---|---|---|---|---|---|---|---|
P1b | M | 31 | NT | 395 | 31,800 | Oropharyngeal chlamydia | BAL/blood |
P1 | M | 31 | 6 Biktarvy | NMb | UDb | None | BAL/blood |
P2 | F | 39 | 84 Biktarvy | 688 | UD | None | BAL/blood |
P3 | F | 51 | 86 Triumeq | 942 | UD | Cocaine user | BAL/blood |
P4 | M | 55 | 72 Triumeq | 356 | UD | None | Blood |
P5 | F | 42 | 60 Descovy, Tivicay | 245 | UD | None | Blood |
H1b | M | 54 | NA | NM | NA | None | BAL/blood |
H2 | M | 45 | NA | NM | NA | None | BAL/blood |
H3 | F | 36 | NA | NM | NA | None | BAL/blood |
H4 | M | 32 | NA | NM | NA | None | Blood |
H5 | F | 24 | NA | NM | NA | None | Blood |